The Evaluation of the Patients with Methemoglobinemia Due to Prilocaine

dc.contributor.authorKaymakcı, Aytekin
dc.contributor.authorGüven, Şirin
dc.contributor.authorArpacık, Mehmet
dc.contributor.authorŞahin, Ceyhan
dc.contributor.authorKahraman Esen, Hayrünisa
dc.contributor.authorYıldız, Turan
dc.date.accessioned2021-12-29T08:12:36Z
dc.date.available2021-12-29T08:12:36Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract: Introduction: This study aims to present the results and treatment of prilocaine-induced methemoglobinemia at threedifferent hospital pediatric surgical clinics.Methods: The data were obtained from hospital information systems at the University of Health Sciences Umraniye Trainingand Research Hospital, Prof. Dr. İlhan Varank Training and Research Hospital and Inonu University Medical Faculty PediatricSurgery clinics between 2009 and 2019. The patients with prilocaine-induced methemoglobinemia in pediatric surgeryclinics were evaluated retrospectively.Results: A total of 11 cases were identified (10 male and 1 female). The mean age was 4.60 months (max/min: 1-12) and themean weight was 5.570 g (max/min: 3600-11000). Local prilocaine (Citanest®), at doses 1-3 mg/kg, was injected to eightcases of circumcision, two cases of bilateral inguinal hernia and one case of undescended testicle + circumcision. In all cases,cyanosis in the skin and mucous membranes and methemoglobin in the blood gases were high (10-30%). 300 mg/kg ascorbicacid was applied to the patients for treatment, and 24 hours of methemoglobin levels were normal (1-3%).Discussion and Conclusion: Methemoglobinemia should be suspected in cases where prilocaine is used as a local anesthetic,especially prilocaine should not be used in infants younger than six months of age, and alternative local anestheticsfor prilocaine should be considered.en_US
dc.identifier.citationKAYMAKCI A,GÜVEN Ş,ARPACIK M,ŞAHİN C,ESEN H. K,YILDIZ T (2019). The Evaluation of the Patients with Methemoglobinemia Due to Prilocaine. Haydarpaşa Numune Medical Journal, 59(4), 351 - 354. Doi: 10.14744/hnhj.2019.38247en_US
dc.identifier.doi10.14744/hnhj.2019.38247en_US
dc.identifier.endpage354en_US
dc.identifier.issn2630-5720
dc.identifier.issue4en_US
dc.identifier.startpage351en_US
dc.identifier.trdizinid327393en_US
dc.identifier.urihttps://doi.org/10.14744/hnhj.2019.38247
dc.identifier.urihttps://hdl.handle.net/11616/44641
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/327393
dc.identifier.volume59en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofHaydarpaşa Numune Medical Journalen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleThe Evaluation of the Patients with Methemoglobinemia Due to Prilocaineen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
4e94d4d5-0bef-487c-809b-c4c45464df0d.pdf
Boyut:
196.48 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: